Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. Company
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo ERYTECH Pharma S.A.
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death.

Number of employees : 206 people.
Managers
Name Title Age Since
Gil Beyen Chief Executive Officer & Director 58 2019
Eric Soyer Chief Operating & Financial Officer 53 -
Iman El-Hariry, Dr. Chief Medical Officer 59 -
Stewart Craig, Dr. Chief Technical Officer 59 2020
Philippe Archinard, Dr. Independent Director 60 2013
Sven Arne Andréasson Independent Director 67 2013
Martine Ortin George, Dr. Independent Director 71 2014
Hilde Windels Independent Director 54 2014
Luc Dochez Independent Director 45 2015
Melanie Rolli, Dr. Independent Director 47 2020
Members of the board
Name Title Age Since
Jean-Paul Kress, Dr. Chairman 54 2019
Philippe Archinard, Dr. Independent Director 60 2013
Gil Beyen Chief Executive Officer & Director 58 2019
Sven Arne Andréasson Independent Director 67 2013
Martine Ortin George, Dr. Independent Director 71 2014
Hilde Windels Independent Director 54 2014
Luc Dochez Independent Director 45 2015
Melanie Rolli, Dr. Independent Director 47 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,438,955 17,835,362 67.5% 2,500 0.0% 67.5%
Shareholders
NameEquities%
BVF Partners LP 3,456,941 12.5%
UBS Group AG 1,978,023 7.13%
Armistice Capital LLC 1,301,473 4.69%
Auriga Partners SA 1,147,522 4.14%
RA Capital Management LP 1,033,225 3.73%
Ecor1 Capital LLC 744,186 2.68%
JPMorgan Asset Management (UK) Ltd. 586,077 2.11%
Recordati Industria Chimica e Farmaceutica S.p.A. 431,034 1.55%
OFI Asset Management SA 115,000 0.41%
Perinvest (UK) Ltd. 100,000 0.36%
Holdings
NameEquities%Valuation
ERYTECH PHARMA S.A. (ERYP) 2,500 0.0090% 14,806 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
- Compartiment C
- CAC Small / CAC All Shares, CAC All-Tradable, CAC Mid Small, EnterNext© PEA-PME 150, Next Biotech, PEA, PEA-PME, Tech 40
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  ERYP.PA
- Datastream Code :  
Company contact information
ERYTECH Pharma S.A.
60 Avenue Rockefeller
FR-69008 Lyon

Phone : +33 (0)4 78 74 44 38
Fax : +33 (0)4 78 75 56 29
web site : https://erytech.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of ERYTECH Pharma S.A.
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-60.34%102
GILEAD SCIENCES, INC.16.25%84 845
BIONTECH SE258.67%71 229
WUXI APPTEC CO., LTD.23.63%64 399
REGENERON PHARMACEUTICALS22.57%59 906
VERTEX PHARMACEUTICALS-22.12%47 992
BEIGENE, LTD.48.47%36 160
GENMAB A/S21.19%30 472
ARGENX SE1.57%14 932
ACCELERON PHARMA INC.35.83%10 626
NEUROCRINE BIOSCIENCES, INC.6.25%9 706
MIRATI THERAPEUTICS, INC.-14.36%9 622
HUALAN BIOLOGICAL ENGINEERING INC.-31.96%8 399
ASCENDIS PHARMA A/S-16.21%8 005
SAREPTA THERAPEUTICS, INC.-53.26%6 929
GW PHARMACEUTICALS PLC89.72%6 907
LEGEND BIOTECH CORPORATION85.62%6 876
ARROWHEAD PHARMACEUTICALS, INC.-13.87%6 865
EXELIXIS, INC.7.92%6 815
REMEGEN CO., LTD.6.63%6 433
ALLAKOS INC.-20.08%5 884